nodes	percent_of_prediction	percent_of_DWPC	metapath
Tazarotene—Retinoids—Bexarotene—hematologic cancer	0.277	0.569	CiPCiCtD
Tazarotene—Retinoids—Alitretinoin—hematologic cancer	0.21	0.431	CiPCiCtD
Tazarotene—RARA—hematologic cancer	0.183	1	CbGaD
Tazarotene—RXRB—Bexarotene—hematologic cancer	0.0677	0.284	CbGbCtD
Tazarotene—RARG—Alitretinoin—hematologic cancer	0.044	0.184	CbGbCtD
Tazarotene—RARA—Alitretinoin—hematologic cancer	0.0389	0.163	CbGbCtD
Tazarotene—RARB—Alitretinoin—hematologic cancer	0.0389	0.163	CbGbCtD
Tazarotene—RXRB—Alitretinoin—hematologic cancer	0.0389	0.163	CbGbCtD
Tazarotene—CYP2C8—Bortezomib—hematologic cancer	0.00328	0.0138	CbGbCtD
Tazarotene—CYP2C8—Ifosfamide—hematologic cancer	0.00252	0.0105	CbGbCtD
Tazarotene—CYP2C8—Nilotinib—hematologic cancer	0.00219	0.00916	CbGbCtD
Tazarotene—CYP2C8—Etoposide—hematologic cancer	0.0012	0.00504	CbGbCtD
Tazarotene—CYP2C8—Dexamethasone—hematologic cancer	0.000989	0.00414	CbGbCtD
Tazarotene—RARG—hematopoietic system—hematologic cancer	0.000921	0.0926	CbGeAlD
Tazarotene—RARA—hematopoietic system—hematologic cancer	0.000866	0.0871	CbGeAlD
Tazarotene—RARA—gonad—hematologic cancer	0.000659	0.0662	CbGeAlD
Tazarotene—RARB—lung—hematologic cancer	0.000656	0.0659	CbGeAlD
Tazarotene—RARG—blood—hematologic cancer	0.00061	0.0614	CbGeAlD
Tazarotene—RXRB—lung—hematologic cancer	0.000603	0.0606	CbGeAlD
Tazarotene—RARA—blood—hematologic cancer	0.000574	0.0577	CbGeAlD
Tazarotene—RXRB—testis—hematologic cancer	0.000569	0.0572	CbGeAlD
Tazarotene—RARA—bone marrow—hematologic cancer	0.000555	0.0558	CbGeAlD
Tazarotene—RARG—lung—hematologic cancer	0.000535	0.0538	CbGeAlD
Tazarotene—RARG—testis—hematologic cancer	0.000505	0.0508	CbGeAlD
Tazarotene—RARA—lung—hematologic cancer	0.000503	0.0506	CbGeAlD
Tazarotene—RARA—testis—hematologic cancer	0.000475	0.0477	CbGeAlD
Tazarotene—RARB—lymph node—hematologic cancer	0.000449	0.0451	CbGeAlD
Tazarotene—RARG—lymph node—hematologic cancer	0.000366	0.0368	CbGeAlD
Tazarotene—RARA—lymph node—hematologic cancer	0.000344	0.0346	CbGeAlD
Tazarotene—CYP2C8—hematopoietic system—hematologic cancer	0.000343	0.0345	CbGeAlD
Tazarotene—CYP2C8—blood—hematologic cancer	0.000227	0.0229	CbGeAlD
Tazarotene—CYP2C8—testis—hematologic cancer	0.000188	0.0189	CbGeAlD
Tazarotene—Pruritus—Clofarabine—hematologic cancer	4.66e-05	0.000908	CcSEcCtD
Tazarotene—Pruritus—Daunorubicin—hematologic cancer	4.66e-05	0.000908	CcSEcCtD
Tazarotene—Skin discolouration—Epirubicin—hematologic cancer	4.66e-05	0.000906	CcSEcCtD
Tazarotene—Pruritus—Pentostatin—hematologic cancer	4.64e-05	0.000904	CcSEcCtD
Tazarotene—Pruritus—Anagrelide—hematologic cancer	4.64e-05	0.000904	CcSEcCtD
Tazarotene—Pain—Bexarotene—hematologic cancer	4.64e-05	0.000903	CcSEcCtD
Tazarotene—Pain—Dasatinib—hematologic cancer	4.64e-05	0.000903	CcSEcCtD
Tazarotene—Inflammation—Methotrexate—hematologic cancer	4.64e-05	0.000902	CcSEcCtD
Tazarotene—Pain—Fludarabine—hematologic cancer	4.63e-05	0.0009	CcSEcCtD
Tazarotene—Erythema—Thiotepa—hematologic cancer	4.57e-05	0.000889	CcSEcCtD
Tazarotene—Haemoglobin—Mitoxantrone—hematologic cancer	4.55e-05	0.000886	CcSEcCtD
Tazarotene—Haemoglobin—Irinotecan—hematologic cancer	4.55e-05	0.000886	CcSEcCtD
Tazarotene—Haemorrhage—Irinotecan—hematologic cancer	4.53e-05	0.000882	CcSEcCtD
Tazarotene—Haemorrhage—Mitoxantrone—hematologic cancer	4.53e-05	0.000882	CcSEcCtD
Tazarotene—Discomfort—Lenalidomide—hematologic cancer	4.48e-05	0.000871	CcSEcCtD
Tazarotene—Oedema—Melphalan—hematologic cancer	4.47e-05	0.00087	CcSEcCtD
Tazarotene—Haemoglobin—Gemcitabine—hematologic cancer	4.44e-05	0.000863	CcSEcCtD
Tazarotene—Discomfort—Hydroxyurea—hematologic cancer	4.42e-05	0.000859	CcSEcCtD
Tazarotene—Haemorrhage—Gemcitabine—hematologic cancer	4.41e-05	0.000859	CcSEcCtD
Tazarotene—Pain—Chlorambucil—hematologic cancer	4.38e-05	0.000853	CcSEcCtD
Tazarotene—Pruritus—Teniposide—hematologic cancer	4.36e-05	0.000848	CcSEcCtD
Tazarotene—Oedema peripheral—Gemcitabine—hematologic cancer	4.35e-05	0.000846	CcSEcCtD
Tazarotene—Oedema—Lenalidomide—hematologic cancer	4.34e-05	0.000845	CcSEcCtD
Tazarotene—Rash—Methoxsalen—hematologic cancer	4.34e-05	0.000844	CcSEcCtD
Tazarotene—Inflammation—Epirubicin—hematologic cancer	4.34e-05	0.000844	CcSEcCtD
Tazarotene—Dermatitis—Methoxsalen—hematologic cancer	4.33e-05	0.000844	CcSEcCtD
Tazarotene—Skin discolouration—Doxorubicin—hematologic cancer	4.31e-05	0.000839	CcSEcCtD
Tazarotene—Skin exfoliation—Methotrexate—hematologic cancer	4.29e-05	0.000835	CcSEcCtD
Tazarotene—Pain—Nilotinib—hematologic cancer	4.29e-05	0.000834	CcSEcCtD
Tazarotene—Oedema—Hydroxyurea—hematologic cancer	4.28e-05	0.000834	CcSEcCtD
Tazarotene—Pain—Imatinib—hematologic cancer	4.26e-05	0.00083	CcSEcCtD
Tazarotene—Erythema—Carmustine—hematologic cancer	4.24e-05	0.000826	CcSEcCtD
Tazarotene—Rash—Mercaptopurine—hematologic cancer	4.21e-05	0.00082	CcSEcCtD
Tazarotene—Dermatitis—Mercaptopurine—hematologic cancer	4.21e-05	0.000819	CcSEcCtD
Tazarotene—Erythema—Alitretinoin—hematologic cancer	4.2e-05	0.000818	CcSEcCtD
Tazarotene—Pain—Cladribine—hematologic cancer	4.19e-05	0.000815	CcSEcCtD
Tazarotene—Dermatitis contact—Epirubicin—hematologic cancer	4.16e-05	0.000809	CcSEcCtD
Tazarotene—Rash—Clofarabine—hematologic cancer	4.16e-05	0.000809	CcSEcCtD
Tazarotene—Rash—Daunorubicin—hematologic cancer	4.16e-05	0.000809	CcSEcCtD
Tazarotene—Erythema—Ifosfamide—hematologic cancer	4.15e-05	0.000808	CcSEcCtD
Tazarotene—Dermatitis—Daunorubicin—hematologic cancer	4.15e-05	0.000808	CcSEcCtD
Tazarotene—Dermatitis—Clofarabine—hematologic cancer	4.15e-05	0.000808	CcSEcCtD
Tazarotene—Rash—Anagrelide—hematologic cancer	4.14e-05	0.000805	CcSEcCtD
Tazarotene—Rash—Pentostatin—hematologic cancer	4.14e-05	0.000805	CcSEcCtD
Tazarotene—Dermatitis—Pentostatin—hematologic cancer	4.13e-05	0.000805	CcSEcCtD
Tazarotene—Dermatitis—Anagrelide—hematologic cancer	4.13e-05	0.000805	CcSEcCtD
Tazarotene—Discomfort—Bortezomib—hematologic cancer	4.12e-05	0.000802	CcSEcCtD
Tazarotene—Dry skin—Dexamethasone—hematologic cancer	4.11e-05	0.0008	CcSEcCtD
Tazarotene—Dry skin—Betamethasone—hematologic cancer	4.11e-05	0.0008	CcSEcCtD
Tazarotene—Discomfort—Bleomycin—hematologic cancer	4.09e-05	0.000796	CcSEcCtD
Tazarotene—Pruritus—Busulfan—hematologic cancer	4.04e-05	0.000786	CcSEcCtD
Tazarotene—Discomfort—Vinorelbine—hematologic cancer	4.02e-05	0.000783	CcSEcCtD
Tazarotene—Pain—Vinblastine—hematologic cancer	4.02e-05	0.000782	CcSEcCtD
Tazarotene—Skin exfoliation—Epirubicin—hematologic cancer	4.02e-05	0.000782	CcSEcCtD
Tazarotene—Inflammation—Doxorubicin—hematologic cancer	4.01e-05	0.000781	CcSEcCtD
Tazarotene—Oedema—Bortezomib—hematologic cancer	4e-05	0.000778	CcSEcCtD
Tazarotene—Rash—Idarubicin—hematologic cancer	3.99e-05	0.000777	CcSEcCtD
Tazarotene—Dermatitis—Idarubicin—hematologic cancer	3.99e-05	0.000776	CcSEcCtD
Tazarotene—Oedema—Bleomycin—hematologic cancer	3.97e-05	0.000772	CcSEcCtD
Tazarotene—Erythema—Mitoxantrone—hematologic cancer	3.94e-05	0.000768	CcSEcCtD
Tazarotene—Pruritus—Procarbazine—hematologic cancer	3.92e-05	0.000762	CcSEcCtD
Tazarotene—Rash—Teniposide—hematologic cancer	3.88e-05	0.000755	CcSEcCtD
Tazarotene—Dermatitis—Teniposide—hematologic cancer	3.88e-05	0.000755	CcSEcCtD
Tazarotene—Dermatitis contact—Doxorubicin—hematologic cancer	3.85e-05	0.000749	CcSEcCtD
Tazarotene—Erythema—Gemcitabine—hematologic cancer	3.84e-05	0.000748	CcSEcCtD
Tazarotene—Pruritus—Bexarotene—hematologic cancer	3.84e-05	0.000747	CcSEcCtD
Tazarotene—Pruritus—Dasatinib—hematologic cancer	3.84e-05	0.000747	CcSEcCtD
Tazarotene—Pruritus—Fludarabine—hematologic cancer	3.83e-05	0.000745	CcSEcCtD
Tazarotene—Pain—Melphalan—hematologic cancer	3.82e-05	0.000744	CcSEcCtD
Tazarotene—Haemoglobin—Prednisolone—hematologic cancer	3.74e-05	0.000727	CcSEcCtD
Tazarotene—Haemorrhage—Prednisolone—hematologic cancer	3.72e-05	0.000723	CcSEcCtD
Tazarotene—Skin exfoliation—Doxorubicin—hematologic cancer	3.72e-05	0.000723	CcSEcCtD
Tazarotene—Discomfort—Thalidomide—hematologic cancer	3.72e-05	0.000723	CcSEcCtD
Tazarotene—Pain—Lenalidomide—hematologic cancer	3.72e-05	0.000723	CcSEcCtD
Tazarotene—Pain—Hydroxyurea—hematologic cancer	3.66e-05	0.000713	CcSEcCtD
Tazarotene—Pruritus—Chlorambucil—hematologic cancer	3.63e-05	0.000706	CcSEcCtD
Tazarotene—Oedema—Thalidomide—hematologic cancer	3.61e-05	0.000702	CcSEcCtD
Tazarotene—Rash—Busulfan—hematologic cancer	3.6e-05	0.0007	CcSEcCtD
Tazarotene—Dermatitis—Busulfan—hematologic cancer	3.59e-05	0.000699	CcSEcCtD
Tazarotene—Erythema—Cisplatin—hematologic cancer	3.58e-05	0.000697	CcSEcCtD
Tazarotene—Dry skin—Prednisone—hematologic cancer	3.58e-05	0.000697	CcSEcCtD
Tazarotene—Pruritus—Nilotinib—hematologic cancer	3.55e-05	0.00069	CcSEcCtD
Tazarotene—Discomfort—Alitretinoin—hematologic cancer	3.54e-05	0.000688	CcSEcCtD
Tazarotene—Pruritus—Imatinib—hematologic cancer	3.53e-05	0.000686	CcSEcCtD
Tazarotene—Discomfort—Ifosfamide—hematologic cancer	3.49e-05	0.00068	CcSEcCtD
Tazarotene—Rash—Procarbazine—hematologic cancer	3.49e-05	0.000679	CcSEcCtD
Tazarotene—Dermatitis—Procarbazine—hematologic cancer	3.49e-05	0.000679	CcSEcCtD
Tazarotene—Pruritus—Cladribine—hematologic cancer	3.47e-05	0.000674	CcSEcCtD
Tazarotene—Oedema—Carmustine—hematologic cancer	3.46e-05	0.000674	CcSEcCtD
Tazarotene—Haemoglobin—Triamcinolone—hematologic cancer	3.44e-05	0.000669	CcSEcCtD
Tazarotene—Oedema—Alitretinoin—hematologic cancer	3.43e-05	0.000668	CcSEcCtD
Tazarotene—Rash—Bexarotene—hematologic cancer	3.42e-05	0.000666	CcSEcCtD
Tazarotene—Rash—Dasatinib—hematologic cancer	3.42e-05	0.000666	CcSEcCtD
Tazarotene—Haemorrhage—Triamcinolone—hematologic cancer	3.42e-05	0.000665	CcSEcCtD
Tazarotene—Pain—Bortezomib—hematologic cancer	3.42e-05	0.000665	CcSEcCtD
Tazarotene—Dermatitis—Bexarotene—hematologic cancer	3.42e-05	0.000665	CcSEcCtD
Tazarotene—Dermatitis—Dasatinib—hematologic cancer	3.42e-05	0.000665	CcSEcCtD
Tazarotene—Rash—Fludarabine—hematologic cancer	3.41e-05	0.000664	CcSEcCtD
Tazarotene—Dermatitis—Fludarabine—hematologic cancer	3.41e-05	0.000663	CcSEcCtD
Tazarotene—Eczema—Epirubicin—hematologic cancer	3.4e-05	0.000661	CcSEcCtD
Tazarotene—Pain—Bleomycin—hematologic cancer	3.39e-05	0.00066	CcSEcCtD
Tazarotene—Oedema—Ifosfamide—hematologic cancer	3.39e-05	0.00066	CcSEcCtD
Tazarotene—Pain—Vinorelbine—hematologic cancer	3.34e-05	0.00065	CcSEcCtD
Tazarotene—Discomfort—Irinotecan—hematologic cancer	3.32e-05	0.000646	CcSEcCtD
Tazarotene—Discomfort—Mitoxantrone—hematologic cancer	3.32e-05	0.000646	CcSEcCtD
Tazarotene—Oedema—Vincristine—hematologic cancer	3.31e-05	0.000643	CcSEcCtD
Tazarotene—Erythema—Prednisolone—hematologic cancer	3.24e-05	0.00063	CcSEcCtD
Tazarotene—Discomfort—Gemcitabine—hematologic cancer	3.23e-05	0.000629	CcSEcCtD
Tazarotene—Oedema—Irinotecan—hematologic cancer	3.22e-05	0.000627	CcSEcCtD
Tazarotene—Oedema—Mitoxantrone—hematologic cancer	3.22e-05	0.000627	CcSEcCtD
Tazarotene—Dermatitis bullous—Epirubicin—hematologic cancer	3.2e-05	0.000622	CcSEcCtD
Tazarotene—Pain—Thiotepa—hematologic cancer	3.19e-05	0.00062	CcSEcCtD
Tazarotene—Pruritus—Melphalan—hematologic cancer	3.16e-05	0.000615	CcSEcCtD
Tazarotene—Rash—Nilotinib—hematologic cancer	3.16e-05	0.000615	CcSEcCtD
Tazarotene—Dermatitis—Nilotinib—hematologic cancer	3.16e-05	0.000615	CcSEcCtD
Tazarotene—Eczema—Doxorubicin—hematologic cancer	3.14e-05	0.000612	CcSEcCtD
Tazarotene—Rash—Imatinib—hematologic cancer	3.14e-05	0.000612	CcSEcCtD
Tazarotene—Dermatitis—Imatinib—hematologic cancer	3.14e-05	0.000611	CcSEcCtD
Tazarotene—Oedema—Gemcitabine—hematologic cancer	3.14e-05	0.00061	CcSEcCtD
Tazarotene—Haemoglobin—Betamethasone—hematologic cancer	3.12e-05	0.000607	CcSEcCtD
Tazarotene—Haemoglobin—Dexamethasone—hematologic cancer	3.12e-05	0.000607	CcSEcCtD
Tazarotene—Haemorrhage—Dexamethasone—hematologic cancer	3.1e-05	0.000604	CcSEcCtD
Tazarotene—Haemorrhage—Betamethasone—hematologic cancer	3.1e-05	0.000604	CcSEcCtD
Tazarotene—Rash—Cladribine—hematologic cancer	3.09e-05	0.000601	CcSEcCtD
Tazarotene—Dermatitis—Cladribine—hematologic cancer	3.09e-05	0.0006	CcSEcCtD
Tazarotene—Pain—Thalidomide—hematologic cancer	3.08e-05	0.0006	CcSEcCtD
Tazarotene—Pruritus—Lenalidomide—hematologic cancer	3.07e-05	0.000598	CcSEcCtD
Tazarotene—Discomfort—Cisplatin—hematologic cancer	3.01e-05	0.000586	CcSEcCtD
Tazarotene—Erythema—Triamcinolone—hematologic cancer	2.98e-05	0.000579	CcSEcCtD
Tazarotene—Pain—Carmustine—hematologic cancer	2.96e-05	0.000576	CcSEcCtD
Tazarotene—Dermatitis bullous—Doxorubicin—hematologic cancer	2.96e-05	0.000575	CcSEcCtD
Tazarotene—Pain—Alitretinoin—hematologic cancer	2.93e-05	0.000571	CcSEcCtD
Tazarotene—Oedema—Cisplatin—hematologic cancer	2.92e-05	0.000569	CcSEcCtD
Tazarotene—Pain—Ifosfamide—hematologic cancer	2.9e-05	0.000564	CcSEcCtD
Tazarotene—Pruritus—Bortezomib—hematologic cancer	2.83e-05	0.00055	CcSEcCtD
Tazarotene—Pain—Vincristine—hematologic cancer	2.83e-05	0.00055	CcSEcCtD
Tazarotene—Rash—Melphalan—hematologic cancer	2.82e-05	0.000548	CcSEcCtD
Tazarotene—Dermatitis—Melphalan—hematologic cancer	2.81e-05	0.000548	CcSEcCtD
Tazarotene—Pruritus—Bleomycin—hematologic cancer	2.81e-05	0.000546	CcSEcCtD
Tazarotene—Dry skin—Epirubicin—hematologic cancer	2.8e-05	0.000545	CcSEcCtD
Tazarotene—Pruritus—Vinorelbine—hematologic cancer	2.76e-05	0.000537	CcSEcCtD
Tazarotene—Discomfort—Etoposide—hematologic cancer	2.76e-05	0.000537	CcSEcCtD
Tazarotene—Pain—Irinotecan—hematologic cancer	2.75e-05	0.000536	CcSEcCtD
Tazarotene—Pain—Mitoxantrone—hematologic cancer	2.75e-05	0.000536	CcSEcCtD
Tazarotene—Rash—Lenalidomide—hematologic cancer	2.74e-05	0.000533	CcSEcCtD
Tazarotene—Dermatitis—Lenalidomide—hematologic cancer	2.74e-05	0.000533	CcSEcCtD
Tazarotene—Discomfort—Prednisolone—hematologic cancer	2.72e-05	0.00053	CcSEcCtD
Tazarotene—Haemoglobin—Prednisone—hematologic cancer	2.72e-05	0.000528	CcSEcCtD
Tazarotene—Haemorrhage—Prednisone—hematologic cancer	2.7e-05	0.000526	CcSEcCtD
Tazarotene—Rash—Hydroxyurea—hematologic cancer	2.7e-05	0.000526	CcSEcCtD
Tazarotene—Erythema—Betamethasone—hematologic cancer	2.7e-05	0.000526	CcSEcCtD
Tazarotene—Erythema—Dexamethasone—hematologic cancer	2.7e-05	0.000526	CcSEcCtD
Tazarotene—Dermatitis—Hydroxyurea—hematologic cancer	2.7e-05	0.000525	CcSEcCtD
Tazarotene—Pain—Gemcitabine—hematologic cancer	2.68e-05	0.000522	CcSEcCtD
Tazarotene—Oedema—Prednisolone—hematologic cancer	2.64e-05	0.000514	CcSEcCtD
Tazarotene—Pruritus—Thiotepa—hematologic cancer	2.64e-05	0.000513	CcSEcCtD
Tazarotene—Dry skin—Doxorubicin—hematologic cancer	2.59e-05	0.000504	CcSEcCtD
Tazarotene—Photosensitivity reaction—Methotrexate—hematologic cancer	2.57e-05	0.000501	CcSEcCtD
Tazarotene—Pruritus—Thalidomide—hematologic cancer	2.55e-05	0.000496	CcSEcCtD
Tazarotene—Rash—Bortezomib—hematologic cancer	2.52e-05	0.000491	CcSEcCtD
Tazarotene—Dermatitis—Bortezomib—hematologic cancer	2.52e-05	0.00049	CcSEcCtD
Tazarotene—Discomfort—Triamcinolone—hematologic cancer	2.5e-05	0.000487	CcSEcCtD
Tazarotene—Rash—Bleomycin—hematologic cancer	2.5e-05	0.000487	CcSEcCtD
Tazarotene—Pain—Cisplatin—hematologic cancer	2.5e-05	0.000486	CcSEcCtD
Tazarotene—Dermatitis—Bleomycin—hematologic cancer	2.5e-05	0.000486	CcSEcCtD
Tazarotene—Rash—Vinorelbine—hematologic cancer	2.46e-05	0.000479	CcSEcCtD
Tazarotene—Dermatitis—Vinorelbine—hematologic cancer	2.46e-05	0.000479	CcSEcCtD
Tazarotene—Oedema—Triamcinolone—hematologic cancer	2.43e-05	0.000473	CcSEcCtD
Tazarotene—Pruritus—Alitretinoin—hematologic cancer	2.43e-05	0.000472	CcSEcCtD
Tazarotene—Photosensitivity reaction—Epirubicin—hematologic cancer	2.41e-05	0.000469	CcSEcCtD
Tazarotene—Pruritus—Ifosfamide—hematologic cancer	2.4e-05	0.000467	CcSEcCtD
Tazarotene—Erythema—Prednisone—hematologic cancer	2.35e-05	0.000458	CcSEcCtD
Tazarotene—Rash—Thiotepa—hematologic cancer	2.35e-05	0.000457	CcSEcCtD
Tazarotene—Dermatitis—Thiotepa—hematologic cancer	2.35e-05	0.000457	CcSEcCtD
Tazarotene—Pain—Etoposide—hematologic cancer	2.29e-05	0.000446	CcSEcCtD
Tazarotene—Rash—Thalidomide—hematologic cancer	2.27e-05	0.000442	CcSEcCtD
Tazarotene—Discomfort—Dexamethasone—hematologic cancer	2.27e-05	0.000442	CcSEcCtD
Tazarotene—Discomfort—Betamethasone—hematologic cancer	2.27e-05	0.000442	CcSEcCtD
Tazarotene—Dermatitis—Thalidomide—hematologic cancer	2.27e-05	0.000442	CcSEcCtD
Tazarotene—Haemoglobin—Methotrexate—hematologic cancer	2.27e-05	0.000442	CcSEcCtD
Tazarotene—Pain—Prednisolone—hematologic cancer	2.26e-05	0.00044	CcSEcCtD
Tazarotene—Haemorrhage—Methotrexate—hematologic cancer	2.26e-05	0.000439	CcSEcCtD
Tazarotene—Photosensitivity reaction—Doxorubicin—hematologic cancer	2.23e-05	0.000434	CcSEcCtD
Tazarotene—Pruritus—Gemcitabine—hematologic cancer	2.22e-05	0.000432	CcSEcCtD
Tazarotene—Oedema—Dexamethasone—hematologic cancer	2.2e-05	0.000429	CcSEcCtD
Tazarotene—Oedema—Betamethasone—hematologic cancer	2.2e-05	0.000429	CcSEcCtD
Tazarotene—Rash—Carmustine—hematologic cancer	2.18e-05	0.000425	CcSEcCtD
Tazarotene—Dermatitis—Carmustine—hematologic cancer	2.18e-05	0.000425	CcSEcCtD
Tazarotene—Rash—Alitretinoin—hematologic cancer	2.16e-05	0.000421	CcSEcCtD
Tazarotene—Dermatitis—Alitretinoin—hematologic cancer	2.16e-05	0.000421	CcSEcCtD
Tazarotene—Rash—Ifosfamide—hematologic cancer	2.14e-05	0.000416	CcSEcCtD
Tazarotene—Dermatitis—Ifosfamide—hematologic cancer	2.14e-05	0.000416	CcSEcCtD
Tazarotene—Haemoglobin—Epirubicin—hematologic cancer	2.12e-05	0.000413	CcSEcCtD
Tazarotene—Haemorrhage—Epirubicin—hematologic cancer	2.11e-05	0.000411	CcSEcCtD
Tazarotene—Rash—Vincristine—hematologic cancer	2.08e-05	0.000406	CcSEcCtD
Tazarotene—Dermatitis—Vincristine—hematologic cancer	2.08e-05	0.000405	CcSEcCtD
Tazarotene—Oedema peripheral—Epirubicin—hematologic cancer	2.08e-05	0.000405	CcSEcCtD
Tazarotene—Pain—Triamcinolone—hematologic cancer	2.08e-05	0.000404	CcSEcCtD
Tazarotene—Rash—Irinotecan—hematologic cancer	2.03e-05	0.000395	CcSEcCtD
Tazarotene—Rash—Mitoxantrone—hematologic cancer	2.03e-05	0.000395	CcSEcCtD
Tazarotene—Dermatitis—Irinotecan—hematologic cancer	2.03e-05	0.000395	CcSEcCtD
Tazarotene—Dermatitis—Mitoxantrone—hematologic cancer	2.03e-05	0.000395	CcSEcCtD
Tazarotene—Discomfort—Prednisone—hematologic cancer	1.98e-05	0.000385	CcSEcCtD
Tazarotene—Rash—Gemcitabine—hematologic cancer	1.98e-05	0.000385	CcSEcCtD
Tazarotene—Dermatitis—Gemcitabine—hematologic cancer	1.98e-05	0.000384	CcSEcCtD
Tazarotene—Erythema—Methotrexate—hematologic cancer	1.97e-05	0.000382	CcSEcCtD
Tazarotene—Haemoglobin—Doxorubicin—hematologic cancer	1.96e-05	0.000382	CcSEcCtD
Tazarotene—Haemorrhage—Doxorubicin—hematologic cancer	1.96e-05	0.00038	CcSEcCtD
Tazarotene—Oedema peripheral—Doxorubicin—hematologic cancer	1.93e-05	0.000375	CcSEcCtD
Tazarotene—Oedema—Prednisone—hematologic cancer	1.92e-05	0.000374	CcSEcCtD
Tazarotene—Pruritus—Etoposide—hematologic cancer	1.89e-05	0.000369	CcSEcCtD
Tazarotene—Pain—Betamethasone—hematologic cancer	1.88e-05	0.000367	CcSEcCtD
Tazarotene—Pain—Dexamethasone—hematologic cancer	1.88e-05	0.000367	CcSEcCtD
Tazarotene—Rash—Cisplatin—hematologic cancer	1.84e-05	0.000359	CcSEcCtD
Tazarotene—Dermatitis—Cisplatin—hematologic cancer	1.84e-05	0.000358	CcSEcCtD
Tazarotene—Erythema—Epirubicin—hematologic cancer	1.84e-05	0.000358	CcSEcCtD
Tazarotene—RARB—Gene Expression—NCOR2—hematologic cancer	1.75e-05	0.000582	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—ELL—hematologic cancer	1.75e-05	0.000581	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—ELL—hematologic cancer	1.75e-05	0.000581	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—NR3C1—hematologic cancer	1.75e-05	0.00058	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	1.75e-05	0.000579	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	1.74e-05	0.000576	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	1.73e-05	0.000575	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTO1—hematologic cancer	1.72e-05	0.000571	CbGpPWpGaD
Tazarotene—Pruritus—Triamcinolone—hematologic cancer	1.72e-05	0.000334	CcSEcCtD
Tazarotene—RARA—Generic Transcription Pathway—CDKN2B—hematologic cancer	1.71e-05	0.000568	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—CDKN2B—hematologic cancer	1.71e-05	0.000568	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	1.71e-05	0.000568	CbGpPWpGaD
Tazarotene—Erythema—Doxorubicin—hematologic cancer	1.7e-05	0.000331	CcSEcCtD
Tazarotene—CYP2C8—Metapathway biotransformation—GSTO1—hematologic cancer	1.7e-05	0.000563	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—NCOR1—hematologic cancer	1.69e-05	0.000562	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—TNF—hematologic cancer	1.69e-05	0.000562	CbGpPWpGaD
Tazarotene—Rash—Etoposide—hematologic cancer	1.69e-05	0.000329	CcSEcCtD
Tazarotene—Dermatitis—Etoposide—hematologic cancer	1.69e-05	0.000328	CcSEcCtD
Tazarotene—RARA—Gene Expression—NCOR2—hematologic cancer	1.68e-05	0.000558	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NCOR2—hematologic cancer	1.68e-05	0.000558	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	1.68e-05	0.000557	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	1.68e-05	0.000556	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	1.67e-05	0.000552	CbGpPWpGaD
Tazarotene—Rash—Prednisolone—hematologic cancer	1.67e-05	0.000324	CcSEcCtD
Tazarotene—Dermatitis—Prednisolone—hematologic cancer	1.66e-05	0.000324	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	1.66e-05	0.000551	CbGpPWpGaD
Tazarotene—Discomfort—Methotrexate—hematologic cancer	1.65e-05	0.000322	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	1.64e-05	0.000544	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—NCOR1—hematologic cancer	1.62e-05	0.000539	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NCOR1—hematologic cancer	1.62e-05	0.000539	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—UGT1A1—hematologic cancer	1.62e-05	0.000537	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—AGO2—hematologic cancer	1.62e-05	0.000536	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—RPS14—hematologic cancer	1.61e-05	0.000536	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	1.61e-05	0.000534	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	1.61e-05	0.000533	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	1.6e-05	0.00053	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—UGT1A1—hematologic cancer	1.6e-05	0.000529	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	1.59e-05	0.000528	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NUP98—hematologic cancer	1.59e-05	0.000527	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—DNMT3B—hematologic cancer	1.58e-05	0.000525	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—H3F3B—hematologic cancer	1.58e-05	0.000525	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	1.57e-05	0.000522	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—NR3C1—hematologic cancer	1.57e-05	0.00052	CbGpPWpGaD
Tazarotene—Pruritus—Dexamethasone—hematologic cancer	1.56e-05	0.000303	CcSEcCtD
Tazarotene—Pruritus—Betamethasone—hematologic cancer	1.56e-05	0.000303	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	1.56e-05	0.000516	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—AGO2—hematologic cancer	1.55e-05	0.000514	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—AGO2—hematologic cancer	1.55e-05	0.000514	CbGpPWpGaD
Tazarotene—Discomfort—Epirubicin—hematologic cancer	1.55e-05	0.000301	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	1.53e-05	0.000509	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NUP214—hematologic cancer	1.53e-05	0.000508	CbGpPWpGaD
Tazarotene—Rash—Triamcinolone—hematologic cancer	1.53e-05	0.000298	CcSEcCtD
Tazarotene—Dermatitis—Triamcinolone—hematologic cancer	1.53e-05	0.000298	CcSEcCtD
Tazarotene—RXRB—Gene Expression—DNMT3B—hematologic cancer	1.52e-05	0.000504	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—DNMT3B—hematologic cancer	1.52e-05	0.000504	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—H3F3B—hematologic cancer	1.52e-05	0.000504	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—H3F3B—hematologic cancer	1.52e-05	0.000504	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	1.51e-05	0.000502	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—NR3C1—hematologic cancer	1.5e-05	0.000498	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NR3C1—hematologic cancer	1.5e-05	0.000498	CbGpPWpGaD
Tazarotene—Oedema—Epirubicin—hematologic cancer	1.5e-05	0.000292	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	1.49e-05	0.000495	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—ESR1—hematologic cancer	1.48e-05	0.000492	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	1.46e-05	0.000483	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	1.45e-05	0.000482	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—RPS14—hematologic cancer	1.45e-05	0.00048	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—NOTCH1—hematologic cancer	1.43e-05	0.000476	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	1.43e-05	0.000475	CbGpPWpGaD
Tazarotene—Discomfort—Doxorubicin—hematologic cancer	1.43e-05	0.000279	CcSEcCtD
Tazarotene—RARB—Gene Expression—NUP98—hematologic cancer	1.43e-05	0.000473	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—HSPB1—hematologic cancer	1.41e-05	0.000468	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—EIF4EBP1—hematologic cancer	1.41e-05	0.000468	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—MTR—hematologic cancer	1.4e-05	0.000465	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	1.39e-05	0.000462	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	1.39e-05	0.000461	CbGpPWpGaD
Tazarotene—Rash—Betamethasone—hematologic cancer	1.39e-05	0.00027	CcSEcCtD
Tazarotene—Rash—Dexamethasone—hematologic cancer	1.39e-05	0.00027	CcSEcCtD
Tazarotene—Oedema—Doxorubicin—hematologic cancer	1.39e-05	0.00027	CcSEcCtD
Tazarotene—RXRB—Gene Expression—RPS14—hematologic cancer	1.39e-05	0.000461	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—RPS14—hematologic cancer	1.39e-05	0.000461	CbGpPWpGaD
Tazarotene—Dermatitis—Dexamethasone—hematologic cancer	1.39e-05	0.00027	CcSEcCtD
Tazarotene—Dermatitis—Betamethasone—hematologic cancer	1.39e-05	0.00027	CcSEcCtD
Tazarotene—RARB—Gene Expression—NUP214—hematologic cancer	1.37e-05	0.000456	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	1.37e-05	0.000456	CbGpPWpGaD
Tazarotene—Pain—Methotrexate—hematologic cancer	1.37e-05	0.000267	CcSEcCtD
Tazarotene—RXRB—Gene Expression—NUP98—hematologic cancer	1.37e-05	0.000453	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NUP98—hematologic cancer	1.37e-05	0.000453	CbGpPWpGaD
Tazarotene—RARA—Adipogenesis—IL6—hematologic cancer	1.37e-05	0.000453	CbGpPWpGaD
Tazarotene—Pruritus—Prednisone—hematologic cancer	1.36e-05	0.000264	CcSEcCtD
Tazarotene—RARG—Gene Expression—SMC1A—hematologic cancer	1.35e-05	0.000448	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	1.34e-05	0.000443	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTT1—hematologic cancer	1.33e-05	0.000443	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	1.33e-05	0.000442	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—ESR1—hematologic cancer	1.33e-05	0.000441	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—H3F3A—hematologic cancer	1.32e-05	0.000439	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NUP214—hematologic cancer	1.32e-05	0.000437	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NUP214—hematologic cancer	1.32e-05	0.000437	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—CREBBP—hematologic cancer	1.3e-05	0.000431	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	1.3e-05	0.000431	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	1.29e-05	0.000427	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—NOTCH1—hematologic cancer	1.29e-05	0.000427	CbGpPWpGaD
Tazarotene—Pain—Epirubicin—hematologic cancer	1.28e-05	0.00025	CcSEcCtD
Tazarotene—RARA—Generic Transcription Pathway—ESR1—hematologic cancer	1.28e-05	0.000423	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—ESR1—hematologic cancer	1.28e-05	0.000423	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—EZH2—hematologic cancer	1.27e-05	0.000421	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—EIF4EBP1—hematologic cancer	1.27e-05	0.00042	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—HSPB1—hematologic cancer	1.27e-05	0.00042	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	1.24e-05	0.000413	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—PARP1—hematologic cancer	1.24e-05	0.000413	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	1.23e-05	0.000409	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—NOTCH1—hematologic cancer	1.23e-05	0.000409	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—NOTCH1—hematologic cancer	1.23e-05	0.000409	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—EIF4EBP1—hematologic cancer	1.21e-05	0.000403	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—EIF4EBP1—hematologic cancer	1.21e-05	0.000403	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—HSPB1—hematologic cancer	1.21e-05	0.000403	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—HSPB1—hematologic cancer	1.21e-05	0.000403	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—SMC1A—hematologic cancer	1.21e-05	0.000402	CbGpPWpGaD
Tazarotene—Rash—Prednisone—hematologic cancer	1.21e-05	0.000235	CcSEcCtD
Tazarotene—Dermatitis—Prednisone—hematologic cancer	1.21e-05	0.000235	CcSEcCtD
Tazarotene—RARG—Gene Expression—HDAC2—hematologic cancer	1.2e-05	0.000398	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—H3F3A—hematologic cancer	1.19e-05	0.000394	CbGpPWpGaD
Tazarotene—Pain—Doxorubicin—hematologic cancer	1.19e-05	0.000231	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.18e-05	0.000392	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—CREBBP—hematologic cancer	1.17e-05	0.000387	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—SMC1A—hematologic cancer	1.16e-05	0.000385	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—SMC1A—hematologic cancer	1.16e-05	0.000385	CbGpPWpGaD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.14e-05	0.00038	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—EZH2—hematologic cancer	1.14e-05	0.000378	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—H3F3A—hematologic cancer	1.14e-05	0.000378	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—H3F3A—hematologic cancer	1.14e-05	0.000378	CbGpPWpGaD
Tazarotene—Pruritus—Methotrexate—hematologic cancer	1.13e-05	0.000221	CcSEcCtD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.13e-05	0.000376	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—CREBBP—hematologic cancer	1.12e-05	0.000371	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—CREBBP—hematologic cancer	1.12e-05	0.000371	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—PARP1—hematologic cancer	1.12e-05	0.00037	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.1e-05	0.000364	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—EZH2—hematologic cancer	1.09e-05	0.000362	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—EZH2—hematologic cancer	1.09e-05	0.000362	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—HDAC2—hematologic cancer	1.08e-05	0.000357	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—PARP1—hematologic cancer	1.07e-05	0.000355	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—PARP1—hematologic cancer	1.07e-05	0.000355	CbGpPWpGaD
Tazarotene—Pruritus—Epirubicin—hematologic cancer	1.06e-05	0.000207	CcSEcCtD
Tazarotene—RARG—Gene Expression—AR—hematologic cancer	1.04e-05	0.000345	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—HDAC2—hematologic cancer	1.03e-05	0.000342	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—HDAC2—hematologic cancer	1.03e-05	0.000342	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	1.03e-05	0.00034	CbGpPWpGaD
Tazarotene—Rash—Methotrexate—hematologic cancer	1.01e-05	0.000197	CcSEcCtD
Tazarotene—Dermatitis—Methotrexate—hematologic cancer	1.01e-05	0.000197	CcSEcCtD
Tazarotene—Pruritus—Doxorubicin—hematologic cancer	9.83e-06	0.000191	CcSEcCtD
Tazarotene—RARB—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	9.67e-06	0.000321	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—CDKN2B—hematologic cancer	9.59e-06	0.000318	CbGpPWpGaD
Tazarotene—Rash—Epirubicin—hematologic cancer	9.47e-06	0.000184	CcSEcCtD
Tazarotene—Dermatitis—Epirubicin—hematologic cancer	9.46e-06	0.000184	CcSEcCtD
Tazarotene—RARB—Gene Expression—AR—hematologic cancer	9.33e-06	0.00031	CbGpPWpGaD
Tazarotene—RARA—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	9.27e-06	0.000307	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTP1—hematologic cancer	9.25e-06	0.000307	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—GSTP1—hematologic cancer	9.12e-06	0.000303	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NCOR1—hematologic cancer	9.1e-06	0.000302	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—AR—hematologic cancer	8.95e-06	0.000297	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—AR—hematologic cancer	8.95e-06	0.000297	CbGpPWpGaD
Tazarotene—Rash—Doxorubicin—hematologic cancer	8.76e-06	0.00017	CcSEcCtD
Tazarotene—Dermatitis—Doxorubicin—hematologic cancer	8.75e-06	0.00017	CcSEcCtD
Tazarotene—RARB—Gene Expression—CDKN2B—hematologic cancer	8.6e-06	0.000285	CbGpPWpGaD
Tazarotene—CYP2C8—Biological oxidations—GSTM1—hematologic cancer	8.5e-06	0.000282	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NR3C1—hematologic cancer	8.42e-06	0.000279	CbGpPWpGaD
Tazarotene—CYP2C8—Metapathway biotransformation—GSTM1—hematologic cancer	8.38e-06	0.000278	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	8.36e-06	0.000277	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—CDKN2B—hematologic cancer	8.25e-06	0.000273	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—CDKN2B—hematologic cancer	8.25e-06	0.000273	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—NCOR1—hematologic cancer	8.16e-06	0.000271	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NCOR1—hematologic cancer	7.82e-06	0.000259	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NCOR1—hematologic cancer	7.82e-06	0.000259	CbGpPWpGaD
Tazarotene—RARG—Generic Transcription Pathway—MYC—hematologic cancer	7.72e-06	0.000256	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—NR3C1—hematologic cancer	7.55e-06	0.00025	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	7.31e-06	0.000242	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—MAPK14—hematologic cancer	7.28e-06	0.000242	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NR3C1—hematologic cancer	7.24e-06	0.00024	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NR3C1—hematologic cancer	7.24e-06	0.00024	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—ESR1—hematologic cancer	7.14e-06	0.000237	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—FTCD—hematologic cancer	7.09e-06	0.000235	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PHYH—hematologic cancer	7.09e-06	0.000235	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GMPS—hematologic cancer	7.09e-06	0.000235	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	7.02e-06	0.000233	CbGpPWpGaD
Tazarotene—RARB—Generic Transcription Pathway—MYC—hematologic cancer	6.92e-06	0.00023	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—NOTCH1—hematologic cancer	6.91e-06	0.000229	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	6.68e-06	0.000222	CbGpPWpGaD
Tazarotene—RXRB—Generic Transcription Pathway—MYC—hematologic cancer	6.64e-06	0.00022	CbGpPWpGaD
Tazarotene—RARA—Generic Transcription Pathway—MYC—hematologic cancer	6.64e-06	0.00022	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	6.61e-06	0.000219	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—MAPK14—hematologic cancer	6.53e-06	0.000217	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SMPD3—hematologic cancer	6.48e-06	0.000215	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	6.47e-06	0.000215	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—ESR1—hematologic cancer	6.41e-06	0.000213	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—MAPK14—hematologic cancer	6.26e-06	0.000208	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—MAPK14—hematologic cancer	6.26e-06	0.000208	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—CREBBP—hematologic cancer	6.26e-06	0.000208	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—NOTCH1—hematologic cancer	6.19e-06	0.000205	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—ESR1—hematologic cancer	6.14e-06	0.000204	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—ESR1—hematologic cancer	6.14e-06	0.000204	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	6.05e-06	0.0002	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—NOTCH1—hematologic cancer	5.94e-06	0.000197	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—NOTCH1—hematologic cancer	5.94e-06	0.000197	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	5.89e-06	0.000195	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—B3GAT1—hematologic cancer	5.67e-06	0.000188	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—DCK—hematologic cancer	5.67e-06	0.000188	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ASNS—hematologic cancer	5.67e-06	0.000188	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—CREBBP—hematologic cancer	5.62e-06	0.000186	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	5.54e-06	0.000184	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—CREBBP—hematologic cancer	5.38e-06	0.000179	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—CREBBP—hematologic cancer	5.38e-06	0.000179	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HDC—hematologic cancer	5.37e-06	0.000178	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	5.01e-06	0.000166	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CDA—hematologic cancer	4.91e-06	0.000163	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PC—hematologic cancer	4.73e-06	0.000157	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GBA—hematologic cancer	4.57e-06	0.000152	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SLC35B2—hematologic cancer	4.57e-06	0.000152	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—MTAP—hematologic cancer	4.18e-06	0.000139	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—MAPK3—hematologic cancer	3.82e-06	0.000127	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—FHL2—hematologic cancer	3.72e-06	0.000124	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—MYC—hematologic cancer	3.72e-06	0.000123	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—AGRN—hematologic cancer	3.65e-06	0.000121	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—IDH2—hematologic cancer	3.46e-06	0.000115	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HMMR—hematologic cancer	3.46e-06	0.000115	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—MAPK3—hematologic cancer	3.43e-06	0.000114	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—MYC—hematologic cancer	3.33e-06	0.000111	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—MAPK3—hematologic cancer	3.29e-06	0.000109	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—MAPK3—hematologic cancer	3.29e-06	0.000109	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	3.26e-06	0.000108	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ARNTL—hematologic cancer	3.26e-06	0.000108	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—MYC—hematologic cancer	3.2e-06	0.000106	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—MYC—hematologic cancer	3.2e-06	0.000106	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ACP5—hematologic cancer	3.17e-06	0.000105	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CA9—hematologic cancer	3.17e-06	0.000105	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—NCOR2—hematologic cancer	3.13e-06	0.000104	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—IDH1—hematologic cancer	2.98e-06	9.87e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTO1—hematologic cancer	2.94e-06	9.76e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—TXN—hematologic cancer	2.94e-06	9.76e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ABCC3—hematologic cancer	2.94e-06	9.76e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SPHK1—hematologic cancer	2.88e-06	9.55e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—UGT1A1—hematologic cancer	2.77e-06	9.18e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SLC22A1—hematologic cancer	2.69e-06	8.93e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CRABP1—hematologic cancer	2.69e-06	8.93e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALOX5—hematologic cancer	2.62e-06	8.7e-05	CbGpPWpGaD
Tazarotene—RARG—Gene Expression—AKT1—hematologic cancer	2.58e-06	8.55e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—NUP98—hematologic cancer	2.54e-06	8.43e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—NCOA3—hematologic cancer	2.47e-06	8.18e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ADCY7—hematologic cancer	2.47e-06	8.18e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—NUP214—hematologic cancer	2.45e-06	8.12e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.42e-06	8.04e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ABCG2—hematologic cancer	2.4e-06	7.96e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—MTR—hematologic cancer	2.4e-06	7.96e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ENO2—hematologic cancer	2.35e-06	7.8e-05	CbGpPWpGaD
Tazarotene—RARB—Gene Expression—AKT1—hematologic cancer	2.31e-06	7.67e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTT1—hematologic cancer	2.28e-06	7.57e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.25e-06	7.45e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—SDC1—hematologic cancer	2.23e-06	7.4e-05	CbGpPWpGaD
Tazarotene—RXRB—Gene Expression—AKT1—hematologic cancer	2.22e-06	7.35e-05	CbGpPWpGaD
Tazarotene—RARA—Gene Expression—AKT1—hematologic cancer	2.22e-06	7.35e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.13e-06	7.07e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.1e-06	6.98e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.01e-06	6.67e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—NQO1—hematologic cancer	1.9e-06	6.29e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CD44—hematologic cancer	1.9e-06	6.29e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.86e-06	6.16e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CYCS—hematologic cancer	1.79e-06	5.95e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	1.78e-06	5.91e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.61e-06	5.32e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTP1—hematologic cancer	1.58e-06	5.25e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.53e-06	5.08e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ABCB1—hematologic cancer	1.5e-06	4.97e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—GSTM1—hematologic cancer	1.45e-06	4.82e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—NCOR1—hematologic cancer	1.45e-06	4.82e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—MTHFR—hematologic cancer	1.28e-06	4.26e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.13e-06	3.76e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3CG—hematologic cancer	1.08e-06	3.58e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—CREBBP—hematologic cancer	1e-06	3.32e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3CD—hematologic cancer	9.49e-07	3.15e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—ALB—hematologic cancer	9.37e-07	3.11e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3R1—hematologic cancer	8.96e-07	2.97e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3CB—hematologic cancer	8.27e-07	2.74e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PTEN—hematologic cancer	7.15e-07	2.37e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—EP300—hematologic cancer	6.82e-07	2.26e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—PIK3CA—hematologic cancer	5.04e-07	1.67e-05	CbGpPWpGaD
Tazarotene—CYP2C8—Metabolism—AKT1—hematologic cancer	4.12e-07	1.37e-05	CbGpPWpGaD
